COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration
Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.
Findings of new research that focuses on the performance of rapid COVID-19 antigen and antibody tests.
Intermountain Healthcare Laboratories credit “adaptiveness” to achieving COVID-19 test milestone.
Joel Lefferts, PhD, of the Geisel School of Medicine at Dartmouth explains three major impacts that SARS-CoV-2 variants may have on testing in clinical laboratories.
With fast, affordable, easy-to-use home testing evidently a top priority, the incoming administration continues to adjust national response to the pandemic.
Findings of a new study published in the CDC’s Morbidity and Mortality Weekly Report (MMWR) that focused on the performance and public utility of Abbott BinaxNOW SARS-CoV-2 antigen test.
Insights into University of Illinois’ COVID-19 testing program using saliva test offer perspective on COVID-19 testing for universities.
Findings of new research that focuses on the performance of rapid COVID-19 antigen and antibody tests.
Intermountain Healthcare Laboratories credit “adaptiveness” to achieving COVID-19 test milestone.
Joel Lefferts, PhD, of the Geisel School of Medicine at Dartmouth explains three major impacts that SARS-CoV-2 variants may have on testing in clinical laboratories.
With fast, affordable, easy-to-use home testing evidently a top priority, the incoming administration continues to adjust national response to the pandemic.
Findings of a new study published in the CDC’s Morbidity and Mortality Weekly Report (MMWR) that focused on the performance and public utility of Abbott BinaxNOW SARS-CoV-2 antigen test.
Insights into University of Illinois’ COVID-19 testing program using saliva test offer perspective on COVID-19 testing for universities.
